Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways - Wikidata - wikimedia - TriplyDB

Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways

Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways

http://www.wikidata.org/entity/Q33573937

about

Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity The Effect of Quercetin on Pro- and Anti-Inflammatory Cytokines in a Prenatally Stressed Rat Model of Febrile Seizures.Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier Mouse models of neurological disorders: a view from the blood-brain barrier.Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.The association of statins plus LDL receptor-targeted liposome-encapsulated doxorubicin increases in vitro drug delivery across blood-brain barrier cells.Brain pericytes increase the lipopolysaccharide-enhanced transcytosis of HIV-1 free virus across the in vitro blood-brain barrier: evidence for cytokine-mediated pericyte-endothelial cell crosstalk Species-Dependent Blood-Brain Barrier Disruption of Lipopolysaccharide: Amelioration by Colistin In Vitro and In Vivo Lipopolysaccharide-induced blood brain barrier permeability is enhanced by alpha-synuclein expression The blood-brain barrier in neurodegenerative disease: a rhetorical perspective.Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.Naloxone and ouabain in ultralow concentrations restore Na+/K+-ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes.Actin filament-associated protein 1 (AFAP-1) is a key mediator in inflammatory signaling-induced rapid attenuation of intrinsic P-gp function in human brain capillary endothelial cells.Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.Opioids and the blood-brain barrier: a dynamic interaction with consequences on drug disposition in brain.Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole.Regulation of P-glycoprotein in renal proximal tubule epithelial cells by LPS and TNF-alpha Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier The role of cerebral vascular NFkappaB in LPS-induced inflammation: differential regulation of efflux transporter and transporting cytokine receptors.Penetration of oseltamivir and its active metabolite into the brain after lipopolysaccharide-induced inflammation in mice.Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease.Tau Proteins Cross the Blood-Brain Barrier.Drug transport into the central nervous system: using newer findings about the blood-brain barriers.Administration of LPS-stimulated autologous macrophages induces α-synuclein aggregation in dopaminergic neurons of rat brain.Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability

P2860

Q27022365-2325C566-245D-4FDC-B2B3-D432C6675F4D Q30524688-AE79882D-2790-4B64-B4E1-963CA7A82B55 Q30532529-863FB260-28FF-4A14-B82B-58351D152A06 Q33712730-E5C14B38-B679-4ABF-A49D-3A877675FA17 Q33900889-338F1A85-90D5-4250-BB39-C31185038FBD Q33938994-09B2FB1E-6A36-4BDD-9036-070679F67EF5 Q34269018-C9C4E203-741A-461D-AEB2-A5A388494C9B Q35855634-A61CA426-E59F-41F4-85FA-AC663AA95F11 Q36446501-6AB4D062-5969-4615-B0CB-48DDC4D6B974 Q37008640-EBBFB392-C75A-4836-8DF7-FA7B65143B2A Q37124122-8C630A88-6FAF-4AF7-A4A6-3C4584F19468 Q37237861-4CAF1734-7B01-4691-9E84-93F4D5C20D15 Q37385549-F77BAA98-276E-4762-AC60-B6702F7FBEAD Q37971834-3DB33FF2-DF43-4081-875F-65BBF5364C09 Q38418990-3BC636E1-238C-42A1-ACEF-74BC40CD85EB Q38719997-A467AFF0-F0D3-4785-9A81-B2F585D8FAE7 Q38816544-3ECB7DEA-00ED-4FDB-B576-7E45569C79BD Q39285381-552C5FAE-584E-48F3-A7BC-CFD4E7651B06 Q39391217-15030654-CE2C-421D-AB75-68DDAC6D59A1 Q39689271-1F26A34C-9F10-4A23-A9A3-2D5BDA0662D7 Q42259826-9E6EDE6B-2C82-492A-A8BC-8CFE3BAD37C7 Q42472232-0324778E-CF35-4944-B378-CA8444BF05C3 Q43265037-58857745-6639-4990-AA69-393F3BA6AE0A Q43707054-12CEAA77-ADAD-4E19-9759-F3E5F1FA9A47 Q48040565-5D58FA4D-8F9A-4C83-87B1-F515D0493A44 Q48489678-69C2B733-EEA5-4FDD-88BC-ACA90C131A0F Q48696952-D03CD849-8209-487C-9707-84B45C5B1C75 Q52689036-15725F14-D399-4AA3-9480-7E9F0093560F Q58696321-85D366CA-536B-44D6-876D-99D459FB2953

P2860

Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways

http://www.wikidata.org/entity/Q33573937

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Lipopolysaccharide impairs blo ...... ric oxide-independent pathways

@ast

Lipopolysaccharide impairs blo ...... ric oxide-independent pathways

@en

Lipopolysaccharide impairs blo ...... ic oxide-independent pathways.

@nl

type

label

Lipopolysaccharide impairs blo ...... ric oxide-independent pathways

@ast

Lipopolysaccharide impairs blo ...... ric oxide-independent pathways

@en

Lipopolysaccharide impairs blo ...... ic oxide-independent pathways.

@nl

prefLabel

Lipopolysaccharide impairs blo ...... ric oxide-independent pathways

@ast

Lipopolysaccharide impairs blo ...... ric oxide-independent pathways

@en

Lipopolysaccharide impairs blo ...... ic oxide-independent pathways.

@nl

P1433

Q33573937-4E47C918-B7A9-47CC-9048-F960A375C963

P1476

Q33573937-7FC6A639-1D54-4B09-B9E4-80DE7D0C6622

P2093

Q33573937-028F61FC-B52B-4DA0-8BF8-AAF2351D38FB

Q33573937-CC688834-2007-49B8-B90E-FCA546B388E6

P2860

Q33573937-12EF8D65-6344-473B-A250-2F31322802DE

Q33573937-151BD39A-7BCA-4CE1-8806-4B99BC503A16

Q33573937-25668420-0828-4E9C-A4BE-34F5360FAC05

Q33573937-2913835E-18C0-4EA4-8208-3D5F541F4712

Q33573937-325CA528-4BF1-4316-8144-B356DC3294DF

Q33573937-3988D46B-C9BD-42CF-A236-845696212C68

Q33573937-4FE04B44-937E-47C9-BEE2-705A6A160380

Q33573937-5BCB16F6-62C4-4663-AF9D-76D5C59FEFB8

Q33573937-5E9A8DD1-89F9-4C98-96CF-515006D25D43

Q33573937-796E8690-94F0-4A41-8215-C5FBE443B2E5

P2888

Q33573937-47E4DC9B-526A-49AD-A754-734D75C83224

P304

Q33573937-A9FE3495-EC96-4045-8163-AE479F14C761

P31

Q33573937-D87607E8-C0E3-4EC0-8AA1-DCBCBD9D51BC

P356

Q33573937-D4314DC1-C030-4E7C-8E4F-9681D90D59D8

P433

Q33573937-7B7723CF-EF82-4776-8880-A7BDE8A15C11

P478

Q33573937-AEC04F28-493F-4062-8163-AC66B2B8FDA4

P50

Q33573937-8DC1D9C7-C4D5-4800-8C85-3B60576B63FD

Q33573937-90A52A52-A31D-4D53-A48F-9D3335A5A7C7

P577

Q33573937-FD14E4C3-11D3-418C-B769-F5D61E48FF0F

P5875

Q33573937-8E8A456A-4E24-4E40-B46A-8E28D53A8123

P6179

Q33573937-F29B6DB1-7D84-447D-8A1E-AD24343A057F

P698

Q33573937-F825E348-F2C4-49D6-8F6F-F1FA161A600F

P921

Q33573937-2F2D23AA-969D-445C-9545-6506F1C4CEE2

Q33573937-76B90EAB-7FE0-47F7-B2CE-43677873F88A

P932

Q33573937-1EE03A52-B313-4F5D-8532-AB3616DCFA51

P356

S11481-008-9138-Y

P1433

Journal of Neuroimmune Pharmacology

P1476

Lipopolysaccharide impairs blo ...... ric oxide-independent pathways

@en

P2093

Jessica L Lynch

http://www.w3.org/2001/XMLSchema#string

Tulin Otamis-Price

http://www.w3.org/2001/XMLSchema#string

P2860

ABC transporters and the blood-brain barrier.

Nitric oxide isoenzymes regulate lipopolysaccharide-enhanced insulin transport across the blood-brain barrier.

Lipopolysaccharide-enhanced transcellular transport of HIV-1 across the blood-brain barrier is mediated by the p38 mitogen-activated protein kinase pathway

Strategies to advance translational research into brain barriers.

Cytokine-to-brain communication: a review & analysis of alternative mechanisms.

Transforming growth factor-beta1 upregulates the tight junction and P-glycoprotein of brain microvascular endothelial cells.

Effect of LPS on the permeability of the blood-brain barrier to insulin.

Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance.

The effect of age on P-glycoprotein expression and function in the Fischer-344 rat.

Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier.

P2888

s11481-008-9138-y

P304

276-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11481-008-9138-Y

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Mohamad A Salkeni

William A Banks

P577

2008-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23503377

http://www.w3.org/2001/XMLSchema#string

P6179

1053644073

http://www.w3.org/2001/XMLSchema#string

P698

19039663

http://www.w3.org/2001/XMLSchema#string

P921

blood–brain barrier

lipopolysaccharide

P932

2802264

http://www.w3.org/2001/XMLSchema#string